THE SOCIETY AT A CROSSROADS - MILESTONES AND IMPERATIVES FOR CANCER CLINICAL-TRIALS

The Society of Surgical Oncology (SSO) has evolved into the leading ac ademic oncologic society for surgeons. Major contributions by members of the SSO include significant participation in cancer clinical trials and basic biomedical research, which should be maintained and enhance d. Progress with outcomes research for basic, translational, and clini cal investigations must be sustained with supportive biomedical techno logy to complete clinical trials in Phases I-IV. Investment in the dev elopment and support of translational researchers is of paramount impo rtance to the future of the discipline.